SUVALENT THERAPEUTICS INC.
Thousand Oaks, United States · Founded 2015
- Headquarters
- Thousand Oaks, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2G
About
Suvalent Therapeutics is a preclinical-stage oncology company developing orally available small-molecule inhibitors of SUMOylation to treat c-Myc-dependent cancers, including colorectal cancer. The company's lead program targets SUMO-activating enzyme E1 using a fragment-based allosteric approach validated through NIH SBIR Phase I and II grants.
Summary
SUVALENT THERAPEUTICS INC. is a Biotech company based in Thousand Oaks, United States, founded in 2015.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/suvalent-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/suvalent-therapeutics-inc" alt="SUVALENT THERAPEUTICS INC. on Indexed.vc" width="260" height="76" /></a>